Nano4Imaging Expands U.S. Production Through Strategic Partnership with Arrotek

Nano4Imaging, a German leader in interventional MRI technology, has announced a major expansion of its U.S. production capabilities through a strategic partnership with Arrotek US. The collaboration will enhance Nano4Imaging's range of minimally invasive devices used in MRI-guided procedures.

Arrotek, with a strong reputation in the medical device sector, will utilize its manufacturing facility in North Attleboro, MA, to oversee the final production and logistics of Nano4Imaging’s EmeryGlide guidewire. Additionally, Arrotek’s expertise in composite component design will support Nano4Imaging in developing new MRI-compatible devices.

Rudolf Schulze Vohren, CEO of Nano4Imaging, emphasized the importance of this partnership in addressing the current shortage of MRI-compatible devices in the U.S. market. He noted that the collaboration strengthens Nano4Imaging’s position as a key player in the rapidly growing interventional MRI market, projected to reach $2.3 billion within the next five years.

Keith Spodek, VP of Operations at Arrotek, expressed enthusiasm for the partnership, highlighting the opportunities it presents for expanding Nano4Imaging’s portfolio. Paul Borm, CTO of Nano4Imaging, echoed this excitement, emphasizing the integration of their TRACKR software, which will enable clinicians to perform safer and more personalized MRI-guided treatments.

Nano4Imaging, based in Düsseldorf, Germany, with a U.S. office in Ohio, specializes in AI-driven software and MRI-compatible devices. Arrotek, a U.S.-based consultancy and manufacturer, is part of the Theragenics group and specializes in minimally invasive medical devices.